维生素D缺乏与心脏骤停复苏后患者重度心源性休克的关联
本研究纳入237例因推测心脏原因导致院外心脏骤停并成功复苏的患者,检测血浆25(OH)D浓度,将重度维生素D缺乏定义为25(OH)D <10 ng/mL,重度心源性休克定义为充分容量复苏后仍需大剂量去甲肾上腺素(>0.5 mcg/kg/min)维持血压的难治性低血压。结果显示42%患者发生重度心源性休克,其维生素D水平显著低于无休克者(10.7 ± 7.0 vs. 13.4 ± 6.2 ng/mL,P = 0.002),重度维生素D缺乏比例更高(63% vs. 34%,P < 0.001)。多因素logistic回归校正混杂因素后,维生素D缺乏与重度心源性休克独立相关(OR 2.71,95% CI 1.42-5.18,P = 0.003)。作者结论认为重度维生素D缺乏与心脏骤停复苏后患者的重度心源性休克及死亡率密切相关。
要点
- 在院外心脏骤停复苏后患者中,重度心源性休克发生率为42%(100/237),其维生素D水平显著低于无休克者(10.7 ± 7.0 vs. 13.4 ± 6.2 ng/mL,P = 0.002)。
- 重度维生素D缺乏(25(OH)D <10 ng/mL)在重度心源性休克患者中更常见(63% vs. 34%,P < 0.001)。
- 多因素logistic回归校正混杂因素后,维生素D缺乏与重度心源性休克独立相关(OR 2.71,95% CI 1.42-5.18,P = 0.003)。
- 重度心源性休克患者更常出现较长心脏骤停时间(29.5 ± 17.0 vs. 22.7 ± 14.0 min,P = 0.001)、左室收缩功能障碍(LVEF <40%,73% vs. 38%,P < 0.001)及基线肾功能不全(65% vs. 37%,P < 0.001)。
- 作者结论认为重度维生素D缺乏与心脏骤停复苏后患者的重度心源性休克及死亡率密切相关。
适用人群与场景
- 因推测心脏原因导致院外心脏骤停并成功复苏的患者。
诊断标准与关键阈值
- 重度心源性休克定义为充分血管内容量替代后仍需大剂量血管升压药输注(去甲肾上腺素 >0.5 mcg/kg/min)的难治性低血压。
- 重度维生素D缺乏定义为血浆25(OH)D浓度 <10 ng/mL。
研究设计与关键结果
- 研究类型为观察性研究,纳入237例患者(男性179例,76%,平均年龄56.5 ± 16.5岁),首次监测心律为可除颤心律者160例(68%),平均心脏骤停时间和CPR时间分别为25.6 ± 15.7 min和22.8 ± 15.0 min。
- 重度心源性休克发生率为42%(100例),平均维生素D水平为12.3 ± 6.7 ng/mL,维生素D缺乏诊断109例(46%)。
- 重度心源性休克患者维生素D水平显著低于无休克者(10.7 ± 7.0 vs. 13.4 ± 6.2 ng/mL,P = 0.002),重度维生素D缺乏比例更高(63% vs. 34%,P < 0.001)。
- 重度心源性休克患者心脏骤停时间更长(29.5 ± 17.0 vs. 22.7 ± 14.0 min,P = 0.001),左室收缩功能障碍(LVEF <40%)更常见(73% vs. 38%,P < 0.001),基线肾功能不全更常见(65% vs. 37%,P < 0.001)。
- 多因素logistic回归校正混杂因素后,维生素D缺乏与心脏骤停后重度心源性休克独立相关(OR 2.71,95% CI 1.42-5.18,P = 0.003)。
证据类型、等级与局限
- 证据类型为观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Vitamin D deficiency is associated with various cardiovascular diseases, including sudden cardiac arrest (SCA). Profound cardiogenic shock is associated with morbidity and mortality in patients with SCA. This study investigated the association of vitamin D deficiency with profound cardiogenic shock in patients resuscitated from SCA.
PATIENTS AND METHODS: We enrolled patients who were successfully resuscitated from out-of-hospital cardiac arrests of a presumed cardiac cause. Profound cardiogenic shock was defined as refractory hypotension requiring high-dose vasopressor infusion (norepinephrine >0.5 mcg/kg/min) despite adequate intravascular volume replacement. Vitamin D levels were measured as plasma 25(OH)D concentrations and severe vitamin D deficiency was defined as 25(OH)D <10 ng/mL.
RESULTS: A total of 237 subjects (179 men (76%), mean age 56.5 ± 16.5 years) were included in this study. The first monitored rhythm was shockable in 160 subjects (68%). Mean arrest time and CPR times were 25.6 ± 15.7 and 22.8 ± 15.0 min, respectively. Profound cardiogenic shock was observed in 100 subjects (42%). The mean vitamin D level was 12.3 ± 6.7 ng/mL, and vitamin D deficiency was diagnosed in 109 subjects (46%). In profound cardiogenic shock subjects, vitamin D levels were significantly lower (10.7 ± 7.0 vs. 13.4 ± 6.2 ng/mL, P = 0.002) and severe vitamin D deficiency was observed more frequently (63% vs. 34%, P < 0.001). Subjects with profound cardiogenic shock were likely to have longer arrest times (29.5 ± 17.0 vs. 22.7 ± 14.0 min, P = 0.001), left ventricular systolic dysfunction (LVEF < 40%, 73% vs. 38%, P < 0.001), and baseline renal dysfunction (65% vs. 37%, P < 0.001). Multivariate logistic analysis indicated that vitamin D deficiency was significantly associated with profound cardiogenic shock after SCA (OR 2.71, 95% CI 1.42-5.18, P = 0.003) after adjusting for confounding variables.
CONCLUSIONS: Severe vitamin D deficiency was strongly associated with profound cardiogenic shock and mortality in patients resuscitated from SCA.
参考来源
- Cha JJ, Wi J. Association of Vitamin D Deficiency with Profound Cardiogenic Shock in Patients Resuscitated From Sudden Cardiac Arrest. Shock. 2020. PMID: 31490356. doi:10.1097/SHK.0000000000001441
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。